20107 results for «»
20107 results
How should I treat my TAVI patients today and ensure future coronary access?
10 May 2021
[WATCH] - PCR Webinar with M. Abdel-Wahab, M. Taramasso and D. Tchétché
Innovative solutions in complex coronary lesions - Part 2
18 May 2022 – From EuroPCR 2022
Consult this session to learn about innovative solutions in complex coronary lesions, thanks to a variety of cases such as: PCI in a patient with absolute contraindication to contrast administration, another kiss in bifurcation, unexplained hypotension and a new mass, and more!
Mastering TAVI in 2020
11 Aug 2022
The PCR Webinars in this series are all accredited. They may be watched independently, although it is preferable to view the full series in the correct order for a prime educational experience.
Coordinator:Darren Mylotte@dmylotte
How should I treat bicuspid aortic stenosis with TAVI?
10 Dec 2020
Watch this PCR Webinar on TAVI with C. De Biase, N. Dumonteil, D. Mylotte and D. Tchétché
How should we treat low risk patients with aortic stenosis?
10 Feb 2021
Watch the replay of this PCR Webinar on TAVI with N. Dumonteil, T. Modine and S. Bleiziffer
Innovative solutions in complex coronary lesions - Part 3
18 May 2022 – From EuroPCR 2022
Watch these videos to discover some innovative solutions in complex coronary lesions, thanks to a selection of cases: a 27-year-old woman with STEMI and multiple culprit lesions, an unusual communication between aorta and the heart, CTO RCA done with retrograde approach with reverse CART technique, and more!
How should the clinical data on TAVI durability impact the clinical practice?
11 Mar 2021
View the replay of this PCR Webinar on TAVI with L. Sondergaard, D. Capodanno, M. Reardon.
Transcatheter Mitral Valve-in-Valve: a safe alternative for an increasing patient population
10 Dec 2020
Discover the replay of this webinar on TAVI with B. Prendergast, S. Berti, S. Redwood and A. Unbehaun.
How should I treat a patient with symptomatic AS using the THV Portico device with the FlexNav delivery system
20 Oct 2020
Discover the replay of this webinar on TAVI with G. Manoharan, F. Bedogni and L. Sondergaard.
TAVI - Aortic Valve Disease
12 Aug 2022
Chief coordinators:Bernard Prendergast
Lars Sondergaard
TAVI in bicuspid aortic valve disease
03 Nov 2019
View thereplay of this webinar on TAVI in bicuspid aortic valve disease, with Bernard Prendergast, Markus Kasel and Won-Keun Kim.
Durable polymer vs. biodegradable polymer DES in patients with ACS undergoing complex PCI: A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial
30 Aug 2022
The HOST-REDUCE-POLYTECH-ACS trial was a randomised, parallel-group multicentre trial with a 2x2 factorial design testing two independent hypotheses, one of which was the non-inferiority of durable polymer drug-eluting stents (DP-DES) to biodegradable polymer drug-eluting stents (BP-DES) in patients with ACS. In this post-hoc analysis, the authors...
Reviewer
TAVI and Coronary access
19 Nov 2019
Discover the replay of this webinar on TAVI and Coronary access, with Lars Sondergaard, Giuseppe Tarantini and Thierry Lefevre
TAVI - Aortic Stenosis
12 Aug 2022
Chief coordinator:Nicolas Dumonteil@nicolasdumonte1
What are the remaining limitations of TAVI?
07 Jun 2018
View thereplay of this webinar on TAVI with N. Dumonteil, A. S. Petronio and D. Blackman.
Raghav Aggarwal
Ghaziabad, Uttar Pradesh, India
Richa Agrawal
Delhi, India
Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI - STRENGTH Study
14 Aug 2022
The STRENGTH study is a multicentre prospective randomised trial investigating whether RenalGuard is superior to standard intravenous hydration in preventing contrast induced nephropathy in patients with chronic kidney disease (CKD) undergoing complex cardiovascular procedures.
Reviewer
Mahesh Ahire
Nashik, India
Khalil Ahmed
Karachi, Pakistan